These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 29667179

  • 1. Characteristics of genomic alterations of lung adenocarcinoma in young never-smokers.
    Luo W, Tian P, Wang Y, Xu H, Chen L, Tang C, Shu Y, Zhang S, Wang Z, Zhang J, Zhang L, Jiang L, Liu L, Che G, Guo C, Zhang H, Wang J, Li W.
    Int J Cancer; 2018 Oct 01; 143(7):1696-1705. PubMed ID: 29667179
    [Abstract] [Full Text] [Related]

  • 2. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
    Tan AC, Lai GGY, Tan GS, Poon SY, Doble B, Lim TH, Aung ZW, Takano A, Tan WL, Ang MK, Tan BS, Devanand A, Too CW, Gogna A, Ong BH, Koh TPT, Kanesvaran R, Ng QS, Jain A, Rajasekaran T, Lim AST, Lim WT, Toh CK, Tan EH, Lim TKH, Tan DSW.
    Lung Cancer; 2020 Jan 01; 139():207-215. PubMed ID: 31835042
    [Abstract] [Full Text] [Related]

  • 3. Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
    Zhao Y, Dong Y, Zhao R, Zhang B, Wang S, Zhang L, Hu M, He Q, Zhang W, Han B.
    Clin Lung Cancer; 2020 Sep 01; 21(5):e355-e362. PubMed ID: 32139332
    [Abstract] [Full Text] [Related]

  • 4. Distinctive targetable genotypes of younger patients with lung adenocarcinoma: a cBioPortal for cancer genomics data base analysis.
    Hou H, Zhang C, Qi X, Zhou L, Liu D, Lv H, Li T, Sun D, Zhang X.
    Cancer Biol Ther; 2020 Sep 01; 21(1):26-33. PubMed ID: 31594446
    [Abstract] [Full Text] [Related]

  • 5. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
    Lim SM, Kim EY, Kim HR, Ali SM, Greenbowe JR, Shim HS, Chang H, Lim S, Paik S, Cho BC.
    Oncotarget; 2016 Apr 26; 7(17):24172-8. PubMed ID: 26992220
    [Abstract] [Full Text] [Related]

  • 6. Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas.
    Sands JM, Nguyen T, Shivdasani P, Sacher AG, Cheng ML, Alden RS, Jänne PA, Kuo FC, Oxnard GR, Sholl LM.
    Lung Cancer; 2020 Feb 26; 140():35-41. PubMed ID: 31855703
    [Abstract] [Full Text] [Related]

  • 7. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
    Wang H, Wang Z, Zhang G, Zhang M, Zhang X, Li H, Zheng X, Ma Z.
    Cancer Med; 2020 Jan 26; 9(2):487-495. PubMed ID: 31769228
    [Abstract] [Full Text] [Related]

  • 8. Genomic Profiling of Lung Adenocarcinoma in Never-Smokers.
    Devarakonda S, Li Y, Martins Rodrigues F, Sankararaman S, Kadara H, Goparaju C, Lanc I, Pepin K, Waqar SN, Morgensztern D, Ward J, Masood A, Fulton R, Fulton L, Gillette MA, Satpathy S, Carr SA, Wistuba I, Pass H, Wilson RK, Ding L, Govindan R.
    J Clin Oncol; 2021 Nov 20; 39(33):3747-3758. PubMed ID: 34591593
    [Abstract] [Full Text] [Related]

  • 9. Next generation sequencing in lung cancer: An initial experience from India.
    Gupta P, Saha K, Vinarkar S, Banerjee S, Choudhury SS, Parihar M, Midha D, Mukherjee G, Lingegowda D, Chatterjee S, ArunsinghS M, Shrimali R, Ganguly S, Dabkara D, Biswas B, Mishra DK, Arora N.
    Curr Probl Cancer; 2020 Jun 20; 44(3):100562. PubMed ID: 32178863
    [Abstract] [Full Text] [Related]

  • 10. Genetic Profiling of Non-Small Cell Lung Cancer in Moroccan Patients by Targeted Next-Generation Sequencing.
    El Zaitouni S, Laraqui A, Ghaouti M, Benzekri A, Kettani F, Boustany Y, Benmokhtar S, Lamrani Alaoui H, El Annaz H, Abi R, Tagajdid MR, El Kochri S, El Mchichi B, Bouaiti EA, Lahlou IA, El Hassani RA, Ennibi K.
    Technol Cancer Res Treat; 2024 Jun 20; 23():15330338241288907. PubMed ID: 39363851
    [Abstract] [Full Text] [Related]

  • 11. Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.
    Zhang Y, Chang L, Yang Y, Fang W, Guan Y, Wu A, Hong S, Zhou H, Chen G, Chen X, Zhao S, Zheng Q, Pan H, Zhang L, Long H, Yang H, Wang X, Wen Z, Wang J, Yang H, Xia X, Zhao Y, Hou X, Ma Y, Zhou T, Zhang Z, Zhan J, Huang Y, Zhao H, Zhou N, Yi X, Zhang L.
    Mol Cancer; 2019 Jan 09; 18(1):7. PubMed ID: 30626401
    [Abstract] [Full Text] [Related]

  • 12. Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer.
    Wei XW, Gao X, Zhang XC, Yang JJ, Chen ZH, Wu YL, Zhou Q.
    Thorac Cancer; 2020 Jun 09; 11(6):1512-1521. PubMed ID: 32291971
    [Abstract] [Full Text] [Related]

  • 13. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
    Schrock AB, Li SD, Frampton GM, Suh J, Braun E, Mehra R, Buck SC, Bufill JA, Peled N, Karim NA, Hsieh KC, Doria M, Knost J, Chen R, Ou SI, Ross JS, Stephens PJ, Fishkin P, Miller VA, Ali SM, Halmos B, Liu JJ.
    J Thorac Oncol; 2017 Jun 09; 12(6):932-942. PubMed ID: 28315738
    [Abstract] [Full Text] [Related]

  • 14. Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.
    Loong HH, Raymond VM, Shiotsu Y, Chua DTT, Teo PML, Yung T, Skrzypczak S, Lanman RB, Mok TSK.
    Clin Lung Cancer; 2018 Sep 09; 19(5):e601-e608. PubMed ID: 29807856
    [Abstract] [Full Text] [Related]

  • 15. Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinoma.
    Gibert J, Clavé S, Hardy-Werbin M, Taus Á, Rocha P, Longarón R, Piquer G, Chaib I, Carcereny E, Morán T, Salido M, Dalmases A, Bellosillo B, Arriola E.
    Lung Cancer; 2020 Feb 09; 140():42-45. PubMed ID: 31862576
    [Abstract] [Full Text] [Related]

  • 16. Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic Profile.
    Hou H, Zhu H, Zhao H, Yan W, Wang Y, Jiang M, Liu B, Liu D, Zhou N, Zhang C, Li P, Chang L, Guan Y, Wang Z, Zhang X, Li Z, Fang B, Zhang X.
    Oncologist; 2018 Sep 09; 23(9):1008-1015. PubMed ID: 29700208
    [Abstract] [Full Text] [Related]

  • 17. Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non-Small-Cell Lung Cancer.
    Sacher AG, Dahlberg SE, Heng J, Mach S, Jänne PA, Oxnard GR.
    JAMA Oncol; 2016 Mar 09; 2(3):313-20. PubMed ID: 26720421
    [Abstract] [Full Text] [Related]

  • 18. Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay.
    Hou H, Yang X, Zhang J, Zhang Z, Xu X, Zhang X, Zhang C, Liu D, Yan W, Zhou N, Zhu H, Qian Z, Li Z, Zhang X.
    Sci Rep; 2017 Nov 06; 7(1):14605. PubMed ID: 29097733
    [Abstract] [Full Text] [Related]

  • 19. Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing.
    Zhou X, Xu X, Tian Z, Xu WY, Cui Y.
    J Cancer Res Clin Oncol; 2020 Sep 06; 146(9):2277-2287. PubMed ID: 32572558
    [Abstract] [Full Text] [Related]

  • 20. Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers.
    Garrido J, Bernal Y, González E, Blanco A, Sepúlveda-Hermosilla G, Freire M, Oróstica K, Rivas S, Marcelain K, Owen G, Ibañez C, Corvalan A, Garrido M, Assar R, Lizana R, Cáceres-Molina J, Ampuero D, Ramos L, Pérez P, Aren O, Chernilo S, Fernández C, Spencer ML, Aguila JF, Dossetto GB, Olea MA, Rasse G, Sánchez C, de Amorim MG, Bartelli TF, Nunes DN, Dias-Neto E, Freitas HC, Armisén R.
    BMC Cancer; 2024 Aug 03; 24(1):951. PubMed ID: 39097719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.